The effect of cochlear size on electrically evoked auditory brainstem responses in deaf children

Zhu, Han-Yu; Sun, Jiaqiang; Sun, Jingwu; Guo, Xiao-Tao

doi:10.1002/lio2.1029

Cited by 5 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The software can also give postoperative feedback to visualize and perform a quality check of the insertion and lead management status. The product has shown success in selection of appropriate CI electrodes in pediatric inner ear malformations 7,8 . It has been proposed that the new version of the software may also be used for BONEBRIDGE placements.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

Wu,

Gorelik,

Brenner

et al. 2024

OTO Open

View full text Add to dashboard Cite

ObjectiveTo review new drugs and devices relevant to otolaryngology approved by the Food and Drug Administration (FDA) in 2022.Data SourcesPublicly available FDA data on drugs and devices approved in 2022.Review MethodsA preliminary screen was conducted to identify drugs and devices relevant to otolaryngology. A secondary screen by members of the American Academy of Otolaryngology–Head and Neck Surgery's (AAO‐HNS) Medical Devices and Drugs Committee differentiated between minor updates and new approvals. The final list of drugs and devices was sent to members of each subspecialty for review and analysis.ConclusionA total of 1251 devices and 37 drugs were identified on preliminary screening. Of these, 329 devices and 5 drugs were sent to subspecialists for further review, from which 37 devices and 2 novel drugs were selected for further analysis. The newly approved devices spanned all subspecialties within otolaryngology. Many of the newly approved devices aimed to enhance patient experience, including over‐the‐counter hearing aids, sleep monitoring devices, and refined CPAP devices. Other advances aimed to improve surgical access, convenience, or comfort in the operating room and clinic.Implications for PracticeMany new devices and drugs are approved each year to improve patient care and care delivery. By staying up to date with these advances, otolaryngologists can leverage new innovations to improve the safety and quality of care. Given the recent approval of these devices, further studies are needed to assess long‐term impact within the field of otolaryngology.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The product has shown success in selection of appropriate CI electrodes in pediatric inner ear malformations. 7 , 8 It has been proposed that the new version of the software may also be used for BONEBRIDGE placements.…”

Section: Discussionmentioning

confidence: 99%

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

Wu,

Gorelik,

Brenner

et al. 2024

OTO Open

View full text Add to dashboard Cite

show abstract

“…OTOPLAN has been utilized to measure the CDL and estimate the frequency allocation map, assisting in selecting the most fitting electrode array [50]. In pediatric CI surgery, it has been observed that the physiological function of the peripheral auditory system is influenced by the anatomical structure of the cochlea, with a larger cochlear size being associated with better auditory conduction function [51].…”

Section: Surgical Planningmentioning

confidence: 99%

Otological Planning Software—OTOPLAN: A Narrative Literature Review

Gatto,

Tofanelli,

Costariol

et al. 2023

Audiology Research

View full text Add to dashboard Cite

The cochlear implant (CI) is a widely accepted option in patients with severe to profound hearing loss receiving limited benefit from traditional hearing aids. CI surgery uses a default setting for frequency allocation aiming to reproduce tonotopicity, thus mimicking the normal cochlea. One emerging instrument that may substantially help the surgeon before, during, and after the surgery is a surgical planning software product developed in collaboration by CASCINATION AG (Bern, Switzerland) and MED-EL (Innsbruck Austria). The aim of this narrative review is to present an overview of the main features of this otological planning software, called OTOPLAN®. The literature was searched on the PubMed and Web of Science databases. The search terms used were “OTOPLAN”, “cochlear planning software” “three-dimensional imaging”, “3D segmentation”, and “cochlear implant” combined into different queries. This strategy yielded 52 publications, and a total of 31 studies were included. The review of the literature revealed that OTOPLAN is a useful tool for otologists and audiologists as it improves preoperative surgical planning both in adults and in children, guides the intraoperative procedure and allows postoperative evaluation of the CI.

show abstract

Relationships between bilateral auditory brainstem activity and inter-implant interval in children with cochlear implants

Wu,

Chen,

Zhu

et al. 2023

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

The effect of cochlear size on electrically evoked auditory brainstem responses in deaf children

Cited by 5 publications

References 23 publications

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

Otological Planning Software—OTOPLAN: A Narrative Literature Review

Relationships between bilateral auditory brainstem activity and inter-implant interval in children with cochlear implants

Contact Info

Product

Resources

About